Stock listing

Xetra:BRM Bristol-Myers Squibb Company Aktie

German listing (Xetra) of Bristol-Myers Squibb Company · home listing NYSE:BMY

Follow Bristol-Myers Squibb Company into a list and get an email when it puts out news.

Share price · XETR:BRM

€55.15 EUR -0.93 (-1.7%)

Close on Oct 23, 2026

Day range
€54.82 – €56.21 EUROct 23, 2026
Volume
1,384 sharesOct 23, 2026
Market cap
€112.7B EURAt the close on Oct 23, 2026 · price × 2.04B shares outstanding
Bristol-Myers Squibb Company logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:BMY · Home$61.48 USD-1.52 (-2.4%)9,762,441$62.66$62.84$61.31$63.00Close on Oct 23, 2026
Xetra:BRM€55.15 EUR-0.93 (-1.7%)1,384€55.93€56.21€54.82€56.08Close on Oct 23, 2026
BMV:BMY$1,185.00 MXN+48.00 (+4.2%)86$1,150.00$1,185.00$1,150.00$1,137.00Close on Oct 22, 2026
B3:BMYB34296.57 BRL-6.61 (-2.2%)150296.57296.57296.57303.18Close on Oct 19, 2026
Frankfurt:BRM€55.46 EUR-0.49 (-0.9%)—€55.83€55.83€55.46€55.95Close on Oct 23, 2026
Munich:BRM€55.81 EUR+1.26 (+2.3%)—€55.81€55.81€55.81€54.55Close on Oct 23, 2026
Hamburg:BRM€55.16 EUR-0.83 (-1.5%)—€55.81€55.94€55.16€55.99Close on Oct 23, 2026
Dusseldorf:BRM€54.98 EUR-0.93 (-1.7%)—€55.77€55.78€54.98€55.91Close on Oct 23, 2026
Ticker
Xetra:BRM
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Xetra
Currency
EUR

What changed lately

Calls

Upcoming

  • Bristol-Myers Squibb (NYSE:BMY) Q3 2026 Earnings Call

    Thu, Oct 29, 2026 · 8:00 AM ET

    Register

Replays

  • Bristol-Myers Squibb (NYSE:BMY) Q2 2026 Earnings Call

    Thu, Jul 30, 2026 · 8:15 AM ET

    Watch Transcript

  • Bristol-Myers Squibb (NYSE:BMY) Q1 2026 Earnings Call

    Thu, Apr 30, 2026 · 8:00 AM ET

    Watch Transcript

  • Bristol-Myers Squibb (NYSE:BMY) Q4 2025 Earnings Call

    Thu, Feb 05, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients with Highly Active Relapsing and Progressive Forms of Multiple Sclerosis at MSToronto 2026

Oct 23, 2026

Izalontamab Brengitecan (Iza-Bren) Reduced Risk of Disease Progression or Death by 59% versus Chemotherapy in Patients with Advanced HR+/HER2- Breast Cancer in Phase 3 PANKU-Breast01 Study

Oct 23, 2026

Bristol Myers Squibb to Showcase Next-Generation Cancer Modalities and Leadership Across Solid Tumors at ESMO 2026

Oct 19, 2026

Bristol Myers Squibb Announces Positive Topline Results from the Interim Analysis of Phase 3 ACTION-1 for RYZ101, RayzeBio’s Radiopharmaceutical Therapy, in Patients with GEP-NETs

Oct 12, 2026

Bristol Myers Squibb Announces Phase 3 ALOFT-IPF Trial Evaluating Admilparant in Adults with Idiopathic Pulmonary Fibrosis Met Primary Endpoint

Oct 12, 2026

On the 12th Edition of Global Patient Week Bristol Myers Squibb and Saudi Schizophrenia Association 'Ehtiwaa' Collaborate to Support People Living with Schizophrenia Through the 'Small Wins' Initiative

Oct 12, 2026

Bristol Myers Squibb Announces ZENBEXUSTM (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates Superior Progression-Free Survival vs. Standard of Care in Relapsed and Refractory Multiple Myeloma in Phase 3...

Oct 8, 2026

Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement

Oct 5, 2026

Driving Community Health: Bristol Myers Squibb, Emirates Thalassemia Society and Dubai Science Park Host the 6th 'Help Save a Life' Blood Donation Drive

Oct 5, 2026

U.S. Food and Drug Administration Approves Expanded Indication for Bristol Myers Squibb’s CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) in Adults and Pediatric Patients*

Sep 30, 2026

All Bristol-Myers Squibb Company news

Decks

Bristol-Myers Squibb Company on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
109 in the last 12 months · 155 in all · newest Oct 23, 2026 · oldest 2025
Calls
31 calls with a replay · 31 with a transcript · latest Jul 30, 2026
Decks
64 decks · latest Jul 30, 2026

Where Bristol-Myers Squibb Company is listed

ListingExchangeCountryCurrency
NYSE:BMY · Home listingNYSEUnited StatesUSD
BCBA:BMYBCBAArgentinaARS
gettex:BRMgettexGermanyEUR
Tradegate:BRMTradegateGermanyEUR
Xetra:BRM · This pageXetraGermanyEUR
BMV:BMYBMVMexicoMXN
LS Exchange:850501LS ExchangeGermanyEUR
Lang & Schwarz:850501Lang & SchwarzGermanyEUR
Stuttgart:BRMStuttgartGermanyEUR
BOATS:BMYBOATSUnited StatesUSD
B3:BMYB34B3BrazilBRL
Milan:1BMYMilanItalyEUR
Frankfurt:BRMFrankfurtGermanyEUR
SIX Swiss:BMYSIX SwissSwitzerlandCHF
BCBA:BMYDBCBAArgentinaUSD
BIVA:BMYBIVAMexicoMXN
SIX Swiss:BMY.USDSIX SwissSwitzerlandUSD
LSIN:0R1FLSINUnited KingdomUSD
Munich:BRMMunichGermanyEUR
EUROTLX:4BMYEUROTLXItalyEUR
Hamburg:BRMHamburgGermanyEUR
Hanover:BRMHanoverGermanyEUR
BVL:BMYUSBVLPeruPEN
BCBA:BMYBBCBAArgentinaARS
Dusseldorf:BRMDusseldorfGermanyEUR
VIE:BMYSViennaAustriaEUR
Aquis:BRMDAquisUnited KingdomEUR
Aquis:BRMDAquisUnited KingdomEUR
BX Swiss:BRMBX SwissSwitzerlandCHF
BCBA:BMYCBCBAArgentinaUSD
Turquoise:BMYNTurquoiseUnited KingdomUSD
BCBA:BMY.CIBCBAArgentinaARS

Log in to ask 6ix AI your own questions about Bristol-Myers Squibb Company.